PMV Pharmaceuticals Inc logo

PMV Pharmaceuticals Inc

NAS:PMVP (USA)  
$ 6.24 -0.13 (-2.04%) 11:08 PM EST
P/E:
At Loss
P/B:
1.32
Market Cap:
$ 302.36M
Enterprise V:
$ 134.55M
Volume:
614.85K
Avg Vol (2M):
444.81K
Volume:
614.85K
Market Cap $:
302.36M
PE Ratio:
At Loss
Avg Vol (2M):
444.81K
Enterprise Value $:
134.55M
PB Ratio:
1.32

Business Description

PMV Pharmaceuticals Inc logo
PMV Pharmaceuticals Inc
NAICS : 541714 SIC : 2833
ISIN : US69353Y1038
Description
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Name Current Vs Industry Vs History
Cash-To-Debt 14.42
Equity-to-Asset 0.9
Debt-to-Equity 0.06
Debt-to-EBITDA -0.16
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -26.1
3-Year EPS without NRI Growth Rate -25.7
3-Year FCF Growth Rate -30.4
Name Current Vs Industry Vs History
5-Day RSI 40.35
9-Day RSI 41.31
14-Day RSI 42.45
6-1 Month Momentum % 45.53
12-1 Month Momentum % -37.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.63
Quick Ratio 16.63
Cash Ratio 16.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.6
Shareholder Yield % -0.54
Name Current Vs Industry Vs History
ROE % -30.08
ROA % -27.42
ROIC % -275.93
ROC (Joel Greenblatt) % -416.45
ROCE % -31.69

Financials (Next Earnings Date:2023-11-08 Est.)

PMVP's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PMVP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

PMV Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.63
Beta 0.93
Volatility % 52.72
14-Day RSI 42.45
14-Day ATR ($) 0.530601
20-Day SMA ($) 6.65225
12-1 Month Momentum % -37.86
52-Week Range ($) 3.84 - 13.02
Shares Outstanding (Mil) 48.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PMV Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

PMV Pharmaceuticals Inc Stock Events

Event Date Price($)
No Event Data

PMV Pharmaceuticals Inc Frequently Asked Questions

What is PMV Pharmaceuticals Inc(PMVP)'s stock price today?
The current price of PMVP is $6.24. The 52 week high of PMVP is $13.02 and 52 week low is $3.84.
When is next earnings date of PMV Pharmaceuticals Inc(PMVP)?
The next earnings date of PMV Pharmaceuticals Inc(PMVP) is 2023-11-08 Est..
Does PMV Pharmaceuticals Inc(PMVP) pay dividends? If so, how much?
PMV Pharmaceuticals Inc(PMVP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1